Immune Checkpoint Inhibitor Rechallenge in Unresectable Hepatocellular Carcinoma: A Multicenter Efficacy and Safety Study. - Chen JK; Wei JL; Yang ZD; Liu SP; Li ZC; Chen K; Qin C; Su Z; Ye L; Li SQ; Liu GX; Meng JY; et al. (Liver cancer, 2026)